This application note compares the resolution capabilities between time-of-flight high resolution mass spectrometery (Tof HRMS) and Orbitrap MS, demonstrating that slow MS scan rates can lead to insufficient data points to define a chromatographic peak. This results in the loss of peak resolution, which can lead to false negatives (missed peaks) in metabolite identification studies and also to significant compromises with quantitative (or semi-quantitative) assessment of major metabolites.
Continuous improvements in chromatography and mass spectrometry have contributed to significant advancements in the study of xenobiotics. In the case of UltraPerformance LC (UPLC), sub-2-micron particle sizes have facilitated DMPK advances including significant improvements in peak capacity and the ability to shorten run times considerably.
Similarly, quadrupole time-of-flight MS (QTof) platforms continue to increase in resolving power (resolution) while maintaining the rapid scanning rate that time of flight instruments are well known for. MSE data acquisition (simultaneous acquisition of full scan and all fragment ions), a generic approach to screening for metabolites has been refined for over a decade. Similar “all-ion” modes of operation are now also available on many competitive high resolution MS (HRMS) platforms. This application note demonstrates that slow MS scan rates can lead to insufficient data points to define a chromatographic peak. This results in the loss of peak resolution, which can lead to false negatives (missed peaks) in metabolite identification studies and also to significant compromises with quantitative (or semi-quantitative) assessment of major metabolites.
The ability to acquire both qualitative and quantitative information using HRMS has made it possible to collect both rate and metabolite structural information from one HRMS instrument during one scheduled run. This is a particularly valuable benefit for pharmaceutical discovery projects that often demand data in a short turnaround time as part of the rapid design/make/test cycle. Such fast sample throughput requirements can now be routinely achieved by using UPLCenabled HRMS systems with gradient run times shorter than three minutes.
Glyburide with a final concentration of 10 μM was incubated in human liver microsomes (2 mg/mL final protein concentration). After preheating the solution containing glyburide and microsome in pH 7.4 phosphate buffer at 37 °C for 5 min, the reaction was started by adding NADPH (2 mM). After one hour of gentle shaking at 37 °C, the reaction was stopped by adding two volumes of cold acetonitrile. The quenched acetonitrile solution was centrifuged for 20 min at 15,000 rpm and 10 °C to precipitate proteins. Finally, the supernatant was transferred to a 2-mL analytical vial and diluted with one volume of H2O.
LC system: |
ACQUITY UPLC I-Class |
Column: |
CORTECS C18+ 1.6 μm, 2.1 x 100 mm |
Column temp.: |
60° C |
Sample temp.: |
10° C |
Injection vol.: |
8 μL |
Flow rate: |
0.6 mL/min |
Mobile phase A: |
H2O with 0.1 % formic acid |
Mobile phase B: |
90% acetonitrile/10% MeOH, with 0.1 % formic acid |
Gradient: |
5-90% B in 2.5 minutes, held at 90% B for 1 min before returning to the initial condition; total run cycle time 5 min |
MS system: |
Xevo G2-S QTof |
Ionization mode: |
ESI+, resolution |
Experiment: |
MSE (Full scan precursor and fragment ion scanning) |
MSE settings: |
Low CE 2.0 eV; high CE Ramp 10-30 eV |
Acquisition mass range: |
50-1200 m/z |
Capillary voltage: |
1 kV |
Cone voltage: |
30 kV |
Source temp.: |
120 °C |
Desolvation gas temp.: |
550 °C |
Cone gas flow: |
20 L/h |
Desolvation gas flow: |
1000 L/h |
Scan time: |
Various, range from 0.08 - 1s tested, see results |
UNIFI Scientific Information System
In this application note, the effect of scan speed on LC and MS chromatographic separation and metabolite identification is systematically tested using an ACQUITY UPLC I-Class System with a Xevo G2-S QTof MS, using glyburide as a model compound.
When we look at MS resolution and scan speed in particular, time-of-flight technology is known to produce essentially the same resolution across an entire mass range, >32.5 K for the Xevo G2-S QTof, across all scan speeds. In contrast, the mass resolution of Orbitrap ion-trapping technology is inversely related to scan speed. Figure 1 plots this relationship using the mass of 500 as an example. Consequently, at the UPLC-compatible faster scan speed settings of 12 and 7 Hz (scan/s), the Tof offers higher resolution. Although highly desirable, using the high-resolution specification settings on the Q Exactive (Thermo Scientific) results in very slow scan speeds of 3.0 and 1.5 Hz. This sampling speed may be insufficient for UPLC data sampling where peak widths of less than 1 second are commonly obtained, and greater than 10 data points are desirable and needed for reproducible quantitation.3
The 2013 review article by Rodriguez-Aller suggests that HRMS based on time-of-flight MS technology is the preferred platform for UPLC data acquisition due to its fast scan rate.1 Similarly, observations by Rousu et al. comparing Tof with Orbitrap technology for metabolite identification, concluded that Tof MS positively identified all metabolites while the Orbitrap MS exhibited lower sensitivity and false negatives due to its slower scan rate.2
Under human microsomal incubation conditions, glyburide undergoes biotransformation to form six major +O metabolites (Figure 2).4 Based on the MS fragmentation pattern, five of the +O metabolites occur on the terminal cyclohexyl group as isomeric metabolites (Figure 2, yellow region).
It should be noted that formation of isomeric and/or isobaric metabolites are commonly observed in metabolism studies. In this regard, mass resolution is very important, but when resolving isomers without appropriate scanning rates and sufficient chromatographic resolution, isomers can be difficult if not impossible to detect, resolve, or quantitate by relying on HRMS alone.
Figure 3 shows a typical HRMS extracted ion chromatogram (XIC) for glyburide obtained under generic gradient conditions and using a Xevo G2-S QTof scan speed of 0.1 seconds (10 scan/s).
Figure 4 summarizes chromatograms collected with varying scan speeds ranging from 0.08 to 0.67 seconds, while keeping other LC-MS parameters constant. These scan times correspond to 12, 7, 3, and 1.5 Hz scanning speeds.
With decreasing scan speed, each peak broadens and fewer data points across each peak are collected (Figure 4). At a scan speed of 0.3 seconds, the middle two peaks merge into one, suggesting a complete loss of peak resolution due to insufficient MS sampling rate. Since these two peaks are isomeric metabolites, increasing MS resolution will not provide differentiation.
Peak smoothing (Figure 4, right side) is typically applied to the raw data before integration to reduce spectrum noise and further improve the XIC quality. Again, results show that with a 0.08 second scan rate, all metabolites are clearly identified, while at 0.3 s, there is further merging of the two middle peaks.
It is not only important to have fast scanning for XIC quality. Figure 5 shows that excellent MSE spectra were obtained at both 0.08 and 0.3 seconds, indicating MS fragmentation data was not compromised when operating the Xevo G2-S QTof at fast scan speeds. The MSE mode of operation offers rich fragmentation information without compromise to resolution, while maintaining sufficient points across the peak for quantification and discrimination of closely eluting peaks.
We have demonstrated that there are significant differences in MS scan rates, and thus resolution, when comparing Orbitrap and time-of-flight MS technologies. Using typical glyburide incubations with multiple hydroxylations (isomers), a slow MS scan rate of 0.3 seconds leads to insufficient data points to define some of the metabolites, resulting in loss of resolution even though the resolution was obtained initially by UPLC separation. Conversely, a 0.08-second scan rate generating good chromatographic resolution of the peaks allows for the simultaneous capture of key MS/MS information at 32.5K resolution.
Since these metabolites have identical masses, MS data with poor chromatographic resolution caused by slower scan rates would fail to provide sufficient detail about some metabolites, resulting in false negatives or metabolites not being correctly identified. If either relative or absolute quantification is required, the peak capacity is also significantly compromised at slower scan speeds.
The analysis of glyburide metabolites in microsomal incubate illustrates the complexity of metabolite samples, which demands the use of a sub-2-micron particle sized column under UPLC conditions to deliver the required separation and quantification. Equally important is a compatible MS detector with a fast scan rate capable of capturing the chromatographic separation.
When the scan speed is insufficient, the LC separated peaks will merge, resulting in loss of peak information and incorrect metabolite assignment. A scan speed of 0.3 seconds was found to be insufficient to separate and identify all glyburide metabolites and resulted in false negatives. With its fast speed and excellent MSE spectra quality, the combination of Waters’ ACQUITY UPLC I-Class and Xevo G2-S QTof technologies offers the best-in-class solution for confidence in metabolite identification.
720004762, March 2013